Once-monthly oral ibandronate improves biomechanical determinants of bone strength in women with postmenopausal osteoporosis

Journal of Clinical Endocrinology and Metabolism

Volumn 94, Issue 1, 2009, Pages 171-180

  Lewiecki, E Michael ^a   Keaveny, Tony M ^b,c   Kopperdahl, David L ^c   Genant, Harry K ^d,e,f   Engelke, Klaus ^g   Fuerst, Thomas ^e,f   Kivitz, Alan ^h   Davies, Richard Y ⁱ   Fitzpatrick, Lorraine A ⁱ  

^a NEW MEXICO CLINICAL RESEARCH AND OSTEOPOROSIS CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c ON Diagnostics   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e SYNARC INC   (United States)

^f Synarc Inc   (Germany)

^g UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^h Altoona Arthritis and Osteoporosis Center   (United States)

ⁱ GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; BONE SPECIFIC ALKALINE PHOSPHATASE; CALCIUM; CARBOXY TERMINAL TELOPEPTIDE; IBANDRONIC ACID; PLACEBO; UNCLASSIFIED DRUG; VITAMIN D;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BONE DENSITY; BONE STRENGTH; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FEMUR; FEMUR NECK; FINITE ELEMENT ANALYSIS; HIP; HUMAN; LUMBAR SPINE; MAJOR CLINICAL STUDY; MULTICENTER STUDY; POSTMENOPAUSE; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; RIGIDITY; SCORING SYSTEM; TRABECULAR BONE; UNSPECIFIED SIDE EFFECT; VERTEBRA;

EID: 58149396245     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2008-1807     Document Type: Article

References (40)

1. Bousson V, Le Bras A, Roqueplan F, Kang Y, Mitton D, Kolta S, Bergot C, Skalli W, Vicaut E, Kalender W, Engelke K, Laredo JD 2006 Volumetric quantitative computed tomography of the proximal femur: relationships linking geometric and densitometric variables to bone strength. Role for compact bone. Osteoporos Int 17:855-864
2. Melton 3rd LJ, Riggs BL, Keaveny TM, Achenbach SJ, Hoffmann PF, Camp JJ, Rouleau PA, Bouxsein ML, Amin S, Atkinson EJ, Robb RA, Khosla S 2007 Structural determinants of vertebral fracture risk. J Bone Miner Res 22:1885-1892
3. Hernandez CJ, Keaveny TM 2006 A biomechanical perspective on bone quality. Bone 39:1173-1181
4. Bouxsein MR, Delmas PD 2008 Considerations for the development of surrogate endpoints for antifracture efficacy of new treatments in osteoporosis: a perspective. J Bone Miner Res 23:1155-1157
5. Hernandez CJ 2008 How can bone turnover modify bone strength independent of bone mass? Bone 42:1014-1020
6. Sornay-Rendu E, Boutroy S, Munoz F, Delmas PD 2007 Alterations of cortical and trabecular architecture are associated with fractures in postmenopausal women, partially independent of decreased BMD measured by DXA: the OFELY study. J Bone Miner Res 22:425-433
7. Bauss F, Dempster DW 2007 Effects of ibandronate on bone quality: preclinical studies. Bone 40:265-273
8. Gasser JA, Ingold P, Venturiere A, Shen V, Green JR 2008 Long-term protective effects of zoledronic acid on cancellous and cortical bone in the ovariectomized rat. J Bone Miner Res 23:544-551
9. Keaveny TM, Donley DW, Hoffmann PF, Mitlak BH, Glass EV, San Martin JA 2007 Effects of teriparatide and alendronate on vertebral strength as assessed by finite element modeling of QCT scans in women with osteoporosis. J Bone Miner Res 22:149-157
10. Hernandez CJ, Gupta A, Keaveny TM 2006 A biomechanical analysis of the effects of resorption cavities on cancellous bone strength. J Bone Miner Res 21:1248-1255
11. Genant HK, Delmas PD, Chen P, Jiang Y, Eriksen EF, Dalsky GP, Marcus R, San Martin J 2007 Severity of vertebral fracture reflects deterioration of bone microarchitecture. Osteoporos Int 18:69-76
12. Eriksen EF, Hodgson SF, Eastell R, Cedel SL, O'Fallon WM, Riggs BL 1990 Cancellous bone remodeling in type I (postmenopausal) osteoporosis: quantitative assessment of rates of formation, resorption, and bone loss at tissue and cellular levels. J Bone Miner Res 5:311-319
13. Tsangari H, Findlay DM, Fazzalari NL 2007 Structural and remodeling indices in the cancellous bone of the proximal femur across adulthood. Bone 40:211-217
14. Epstein S 2007 Is cortical bone hip? What determines cortical bone properties? Bone 41:S3-S8
15. Borah B, Dufresne TE, Chmielewski PA, Gross GJ, Prenger MC, Phipps RJ 2002 Risedronate preserves trabecular architecture and increases bone strength in vertebra of ovariectomized minipigs as measured by three-dimensional microcomputed tomography. J Bone Miner Res 17:1139-1147
16. Recker RR, Weinstein RS, Chesnut 3rd CH, Schimmer RC, Mahoney P, Hughes C, Bonvoisin B, Meunier PJ 2004 Histomorphometric evaluation of daily and intermittent oral ibandronate in women with postmenopausal osteoporosis: results from the BONE study. Osteoporos Int 15:231-237
17. Recker RR, Delmas PD, Halse J, Reid IR, Boonen S, Garcia-Hernandez PA, Supronik J, Lewiecki EM, Ochoa L, Miller P, Hu H, Mesenbrink P, Hartl F, Gasser J, Eriksen EF 2008 Effects of intravenous zoledronic acid once yearly on bone remodeling and bone structure. J Bone Miner Res 23:6-16
18. McClung MR, Geusens P, Miller PD, Zippel H, Bensen WG, Roux C, Adami S, Fogelman T, Diamond T, Eastell R, Meunier PJ, Reginster JY, Hip Intervention Program Study Group 2001 Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group. N Engl J Med 344:333-340
19. Silverman SL, Watts NB, Delmas PD, Lange JL, Lindsay R 2007 Effectiveness of bisphosphonates on nonvertebral and hip fractures in the first year of therapy: the risedronate and alendronate (REAL) cohort study. Osteoporos Int 18:25-34
20. Watts NB, Worley K, Solis A, Doyle J, Sheer R 2004 Comparison of risedronate to alendronate and calcitonin for early reduction of fracture risk: results from a managed care administrative claims database. J Manag Care Pharm 10:142-151
21. Harris ST, Blumentals WA, Miller PD 2008 Ibandronate and the risk of nonvertebral and clinical fractures in women with postmenopausal osteoporosis: results of a meta-analysis of phase III studies. Curr Med Res Opin 24:237-245
22. Engelke K, Adams JE, Armbrecht G, Augat P, Bogado CE, Bouxsein ML, Felsenberg D, Ito M, Prevrhal S, Hans DB, Lewiecki EM 2008 Clinical use of quantitative computed tomography and peripheral quantitative computed tomography in the management of osteoporosis in adults: the 2007 ISCD Official Positions. J Clin Densitom 11:123-162
23. Keaveny TM, Hoffmann PF, Kopperdahl DL, Donley DW, Krohn K, Glass EV, Mitlak BH 2007 Comparison of the effects of teriparatide and alendronate on parameters of total hip strength as assessed by finite element analysis: results from the Forteo and Alendronate Comparison Trial (abstract 1089). J Bone Miner Res 22(Suppl 1):S26
24. Prevrhal S, Shepherd JA, Faulkner KG, Gaither KW, Black DM, Lang TF 2008 Comparison of DXA hip structural analysis with volumetric QCT. J Clin Densitom 11:232-236
25. Keyak JH 2001 Improved prediction of proximal femoral fracture load using nonlinear finite element models. Med Eng Phys 23:165-173
26. Crawford RP, Cann CE, Keaveny TM 2003 Finite element models predict in vitro vertebral body compressive strength better than quantitative computed tomography. Bone 33:744-750
27. Orwoll ES Marshall LM, Nielson CM, Cummings SR, Lapidus J, Cauley JA, Ensrud K, Lane N, Hoffmann PF, Kopperdahl DL, Keaveny TM 2 December 2008 Finite element analysis of the proximal femur and hip fracture risk in older men. J Bone Miner Res [Epub ahead of print]
28. Bonnick SL 2007 HSA: beyond BMD with DXA. Bone 41:S9-S12
29. Beck TJ, Looker AC, Ruff CB, Sievanen H, Wahner HW 2000 Structural trends in the aging femoral neck and proximal shaft: analysis of the Third National Health and Nutrition Examination Survey dual-energy X-ray absorptiometry data. J Bone Miner Res 15:2297-2304
30. van Londen GJ, Perera S, Vujevich KT, Sereika SM, Bhattacharya R, Greenspan SL 2008 Effect of risedronate on hip structural geometry: a 1-year, double-blind trial in chemotherapy-induced postmenopausal women. Bone 43:274-278
31. Mastmeyer A, Engelke K, Fuchs C, Kalender WA 2006 A hierarchical 3D segmentation method and the definition of vertebral body coordinate systems for QCT of the lumbar spine. Med Image Anal 10:560-577
32. Kang Y, Engelke K, Fuchs C, Kalender WA 2005 An anatomic coordinate system of the femoral neck for highly reproducible BMD measurements using 3D QCT. Comput Med Imaging Graph 29:533-541
33. Engelke K, Fuerst T, Enslin MB, Davies RY, Fitzpatrick LA, Ethgen D, Genant HK 2008 Regional differences of spinal BMD changes after one year once-monthly ibandronate as measured by 3D QCT. Proc International Bone Density Workshop, June 15-19, 2008, Foggia, Italy (oral presentation 08-3)
34. Keaveny TM, Hoffmann PF, Singh M, Palermo L, Bilezikian JP, Greenspan SL, Black DM 2008 Femoral bone strength and its relation to cortical and trabecular changes after treatment with PTH, alendronate, and their combination as assessed by finite element analysis of QCT scans. J Bone Miner Res 23:1974-1982
35. Pinilla TP, Boardman KC, Bouxsein ML, Myers ER, Hayes WC 1996 Impact direction from a fall influences the failure load of the proximal femur as much as age-related bone loss. Calcif Tissue Int 58:231-235
36. Eswaran SK, Gupta A, Adams MF, Keaveny TM 2006 Cortical and trabecular load sharing in the human vertebral body. J Bone Miner Res 21:307-314
37. Mosekilde L, Mosekilde L 1990 Sex differences in age-related changes in vertebral body size, density and biomechanical competence in normal individuals. Bone 11:67-73
38. Greenspan SL, Beck TJ, Resnick NM, Bhattacharya R, Parker RA 2005 Effect of hormone replacement, alendronate, or combination therapy on hip structural geometry: a 3-year, double-blind, placebo-controlled clinical trial. J Bone Miner Res 20:1525-1532
39. Uusi-Rasi K, Semanick LM, Zanchetta JR, Bogado CE, Eriksen EF, Sato M, Beck TJ 2005 Effects of teriparatide [rhPTH (1-34)] treatment on structural geometry of the proximal femur in elderly osteoporotic women. Bone 36:948-958
40. Fuerst T, Beck TJ, Gaither K, Kothari M, Genant HK 2006 Effect of oral ibandronate on hip structure: results from the BONE study (abstract Su323). J Bone Miner Res 21(Suppl 1):S287